New Key Statistics Module, Z-Score and F-Score
NAS:FUSN Key Ratios
| Market Cap $ M | 1,833.04 |
| Enterprise Value $ M | 1,687.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.56 |
| Price/Sales | 718.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -1.42 |
| Beneish M-Score | -1.08 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -23.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -17.23 |
| EV-to-EBITDA | -17.48 |
| PEG | -- |
| Shares Outstanding M | 85.06 |
| Net Margin (%) | -5,111.57 |
| Operating Margin % | -5,403.78 |
| Pre-tax Margin (%) | -5,084.07 |
| Quick Ratio | 10.64 |
| Current Ratio | 10.64 |
| ROA % (ttm) | -37.30 |
| ROE % (ttm) | -49.35 |
| ROIC % (ttm) | -159.30 |
| Dividend Yield % | -- |
| Altman Z-Score | 11.39 |
FUSN Number of Guru Trades
FUSN Volume of Guru Trades
Gurus Latest Trades with NAS:FUSN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FUSN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Fusion Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:FUSN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers